Latest Forum Topics / Biosensors | Post Reply |
Is Biosensors a good buy?
|
|||||
Cookie
Member |
11-Dec-2012 16:38
|
||||
x 0
x 0 Alert Admin |
here he come again.... geezz | ||||
Useful To Me Not Useful To Me | |||||
New123
Elite |
11-Dec-2012 16:13
|
||||
x 0
x 0 Alert Admin |
i think it has exhausted. is gd to take profit. the most it will goes up to 1.24 and more likely it will goes down.. ( history always repeat itself..)  | ||||
Useful To Me Not Useful To Me | |||||
|
|||||
infancybird
Senior |
11-Dec-2012 15:49
|
||||
x 0
x 0 Alert Admin |
Ya, this irritating guy is again selling aggressively at SGD  1.20 to press Bio down. Amaze at his endless sale stock supply.    Hope one day can exhaust his holding for Bio to breakout.
|
||||
Useful To Me Not Useful To Me | |||||
Cookie
Member |
11-Dec-2012 15:39
|
||||
x 0
x 0 Alert Admin |
on the dot man.. they abs damn effective | ||||
Useful To Me Not Useful To Me | |||||
karlbet
Member |
11-Dec-2012 15:24
|
||||
x 0
x 0 Alert Admin |
I suggest you check out the adv and disadvof Biosensers here! < a href=&http://quot http://books.google.co.in/books?id=1f4kyTid13oC& pg=PA4& lpg=PA4& dq=advantages+and+disadvantages+of+biosensors& source=bl& ots=Uwuyw9dqE9& sig=UosfO8UpxGDR4-RNJLnkeGOSzMg& hl=en& sa=X& ei=3d7GUNCDDZGTiAfW2oHADA& redir_esc=y#v=onepage& q=advantages%20and%20disadvantages%20of%20biosensors& f=false" > Biosensors< /a> |
||||
Useful To Me Not Useful To Me | |||||
|
|||||
raykee
Senior |
11-Dec-2012 15:13
|
||||
x 0
x 0 Alert Admin |
i was happy when it hit 1.210, but it did not last long..... i tink the fellow going to sell again soon.... today if close 1.2 should b happy liao | ||||
Useful To Me Not Useful To Me | |||||
Cookie
Member |
11-Dec-2012 15:01
|
||||
x 0
x 0 Alert Admin |
it's moving.... | ||||
Useful To Me Not Useful To Me | |||||
raykee
Senior |
11-Dec-2012 13:14
|
||||
x 0
x 0 Alert Admin |
1.185 got resistance..... when they gonna give a good announcement sia... | ||||
Useful To Me Not Useful To Me | |||||
|
|||||
p_for_profit
Member |
11-Dec-2012 10:49
|
||||
x 0
x 0 Alert Admin |
same here, got small profit now and pretty sure it will go higher..hopefully..fingers crossed..!
|
||||
Useful To Me Not Useful To Me | |||||
edchai
Senior |
11-Dec-2012 09:49
|
||||
x 0
x 0 Alert Admin |
it comes back slowly now and I am waiting for my time to take profit. | ||||
Useful To Me Not Useful To Me | |||||
junction
Senior |
11-Dec-2012 08:50
|
||||
x 0
x 0 Alert Admin |
Is there anyone who can identify this short seller/group of short sellers?  Inspite of the strong fundermentals of Big, they were able to push the price down sharply probably due to the small volume of trade done daily in the last few months.  It is harder now for them since the daily volume has increased but still below the average of  @7 million when Big was active last time.  Also the buy back up to $1.17+ by the company will provide the support.  It is positive that despite no buyback since Dec 4, the price has been able to climb, though slowly, which make the climb  more sustainable.  I believe the big breakout will come if the shortists reverses course and start to cover their shorts.  Ultimately the price should move towards the mean.
|
||||
Useful To Me Not Useful To Me | |||||
yiming2000
Senior |
11-Dec-2012 04:52
|
||||
x 0
x 0 Alert Admin |
Why the fear? Why are people afraid to buy Biosensors? They chased it up to 1.72 and then ran away even though the strong fundamentals have not changed. Why the fear? I would like to smack these cowards. | ||||
Useful To Me Not Useful To Me | |||||
|
|||||
p_for_profit
Member |
10-Dec-2012 19:19
|
||||
x 0
x 0 Alert Admin |
Slow but steady!! I like this.. | ||||
Useful To Me Not Useful To Me | |||||
starlene
Elite |
10-Dec-2012 18:28
|
||||
x 0
x 0 Alert Admin |
No more daily buy back,yet the share price can hold and even move up..good sign
|
||||
Useful To Me Not Useful To Me | |||||
raykee
Senior |
10-Dec-2012 16:53
|
||||
x 0
x 0 Alert Admin |
he bring the price down again... | ||||
Useful To Me Not Useful To Me | |||||
skk888
Veteran |
10-Dec-2012 15:24
|
||||
x 0
x 0 Alert Admin |
yup, i can see that there's really strong buyer(s) today.. probably a BB is in now to push it up... wish us luck...
|
||||
Useful To Me Not Useful To Me | |||||
infancybird
Senior |
10-Dec-2012 14:43
|
||||
x 0
x 0 Alert Admin |
This irritating short seller is very determined to sell down Biosensor price. He is now being cornered inspite of his persistent sale  but another group of stronger buyers is pushing up the price. Looks like the buyer is winning finally.Those day of easy sell down may be over . keep it up Bio.
|
||||
Useful To Me Not Useful To Me | |||||
skk888
Veteran |
10-Dec-2012 12:13
|
||||
x 0
x 0 Alert Admin |
Seems like its going to move.. Re entered again. :) | ||||
Useful To Me Not Useful To Me | |||||
Splendid88
Member |
10-Dec-2012 11:07
|
||||
x 0
x 0 Alert Admin |
Ocbc report is solid. Stock should recover to previous high on back of excellent fundamentals .
|
||||
Useful To Me Not Useful To Me | |||||
starlene
Elite |
10-Dec-2012 10:52
|
||||
x 0
x 0 Alert Admin |
Biosensor went up probably due to..   Healthcare Sector OCBC on 7 Dec 2012 As we move into 2013, we remain sanguine on the growth prospects of the healthcare sector, as robust industry fundamentals are structural and entrenched in nature. This implies that the underlying drivers such as a growing and fast-aging population, rising affluence, increasing incidence and morbidity of diseases and burgeoning medical tourism activities would likely persist in the long run. The healthcare sector offers investors a unique investment proposition, given its resilient and defensive earnings, while growth opportunities are also favourable in light of the aforementioned factors. The sector also saw the high profile IPOs of IHH Healthcare Berhad and Religare Health Trust in 2012, thus giving investors more options to gain exposure to the thriving regional healthcare scene. We reiterate our OVERWEIGHT rating on the healthcare sector, and recommend Biosensors International Group [BUY FV: S$1.69] as our top pick, given its superior stent technology, healthy financial position and compelling valuations. We also like Raffles Medical Group [BUY FV: S$2.82] for its capable management team and strong track record. Year in review The FTSE ST Health Care Index (FSTHC) has turned in a muted showing this year thus far, declining 7.4% YTD and underperforming the broader market. We believe this was caused by the drag from Biosensors International Group’s (BIG) weak share price performance, which carries a substantial weight in the index (prior to the listing of IHH). Nevertheless, we believe that the strong sell-off in BIG’s stock since Apr has been overdone. We expect the group to continue its market share gains, underpinned by its technologically superior drug-eluting stent (DES) platform, which should mitigate the challenges in the DES industry. Meanwhile, the healthcare sector also saw the high profile IPOs of IHH Healthcare Berhad (IHH) and Religare Health Trust (RHT) in 2012. We opine that these listings have created additional limelight on the sector and also offer investors a proxy to the thriving regional healthcare scene. Robust fundamentals to drive growth ahead We are still sanguine on the growth prospects of the healthcare sector as we move into 2013, as robust industry fundamentals are structural and entrenched in nature. This implies that the underlying growth drivers such as a growing and fast-aging population, rising affluence, increasing incidence and morbidity of diseases and burgeoning medical tourism activities would likely persist in the long run. Maintain OVERWEIGHT BIG our top pick for 2013 We opine that the healthcare sector offers investors a unique investment proposition. This is because healthcare companies in general are relatively more resilient in nature due to their defensive earnings, while growth opportunities are also favourable given the aforementioned factors. This has allowed the healthcare sector to command a valuation premium to the broader market, in our opinion. We thus reiterate our OVERWEIGHT rating on the healthcare sector. However, we are cognisant of certain risk factors which could impact the margins and earnings of healthcare companies, such as rising staff and consumables cost (healthcare service providers) and price cuts (medical device and pharmaceutical companies). Within the sector, we recommend BIG [BUY FV: S$1.69] as our top pick, given its healthy financial position and compelling valuations. We also like Raffles Medical Group [BUY FV: S$2.82] for its capable management team and strong track record. |
||||
Useful To Me Not Useful To Me |